台灣於2022年間開始流行嚴重急性呼吸道症候群冠狀病毒2型-Omicron變異株（SARSCoV-2 Omicron variant, Omicron），短短數月間，確診人數已達七百多萬，死亡人數也已破萬。本文提出了4個於2022年5月到6月間的新冠肺炎死亡案例，這些案例皆屬於高齡的慢性病危險族群，有的接受積極治療，有的採取安寧緩和照護，其死亡的直接因素皆不一樣，故藉此探討臨床照顧上的相關議題，以及如何面對此一新興疾病。

In 2022, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant began to emerge in Taiwan. Within a few months, the number of confirmed cases reached over 7,000,000, and the death toll exceeded 10,000. This article reports 4 cases of SARS-CoV-2 deaths between the period of May to June 2022. These cases were of the elderly chronic diseases risk group, and some patients underwent active treatment, while the remainder received palliative care. The direct causes for their deaths were different. This study investigated the associated clinical care issues, including the approaches to combat this novel and emerging disease.